VIE Equity Snapshot

LUNB Weekly Equity Report

H. Lundbeck A/S

Interactive chart JSON snapshot
Latest Close 5.84 EUR 12 Jun 2026
1W Return -1.9% latest completed week
4W Return 6.1% short-term follow-through
12W Return 16.7% quarterly tape
Trend Breadth 80.8% 42 of 52 weeks active
Volume Ratio 1.4x vs 13-week average
Company Brief

What the company does

H. Lundbeck A/S engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally. The company offers Abilify Maintena/ Abilify Asimtufii for schizophrenia and bipolar I disorder in adults; Brintellix/Trintellix to treat depressive disorders; Rexulti/Rxulti to treat major depressive disorder and schizophrenia; Vyepti for migraine prevention; and Cipralex/Lexapro for depression. It also provides Northera for symptomatic neurogenic orthostatic hypotension; Onfi for epilepsy; Sabril for refractory complex partial seizures and infantile spasms; Ebixa for dementia, Azilect for Parkinson's disease; Xenazine for chorea; Deanxit for …

Snapshot

What the weekly tape is saying

LUNB closed the latest completed week at 5.84 EUR. The 4-week return is 6.1% and the 12-week return is 16.7%. Trend Signal is active, Market Dynamics is 0.91. Setup signature: Balanced read with a 67/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 19.3%
Volume 1.4x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 76 Persistence of active Trend Signal over the last year and current streak.
Momentum 79 Blend of 4-week and 12-week follow-through.
Dynamics 65 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 62 Relative leadership and short-term RS change.
Volume 59 Participation compared with the 13-week volume baseline.
Risk Control 62 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
4.90 EUR
Vs Trend Line
19.3%
Fair Value
3.59 EUR
Vs Fair Value
62.7%
52W High
6.03 EUR
52W Low
3.46 EUR
Drawdown
-3.1%
Range Position
92.8%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -1.9%
4W 6.1%
12W 16.7%
26W 30.1%
52W 43.8%

Trend read

Active Streak
9 weeks
52W Active Weeks
42
52W Active Breadth
80.8%
Sector Scope
AT Healthcare
Sector Rank
71 of 112
Sector Percentile
36.9%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
0.91
4W MD Change
-13.1%
Relative Strength
4.49
4W RS Change
-21.5%
Expectation
Positive
Probability
56.02%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
3.7K
13W Average
2.6K
52W Average
1.2K
Vs 13W
1.4x
Vs 52W
3.2x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
7.9%
52W Volatility
5.4%
Upside Weeks
29
Downside Weeks
22
Downside Breadth
42.3%
Avg Gain / Loss
3.8% / -3.1%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
VIE
Country
AT
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
EUR
Market Cap
5.8B

Opportunity signals

  • Trend Signal is active with a 9-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Market Dynamics is positive on the latest completed week.

Risk signals

  • Recent volatility is running well above the one-year baseline.

Watch next

  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 5.84 EUR -1.9% 4.90 EUR 3.59 EUR 0.91 4.49 3.7K On
5 Jun 2026 5.96 EUR 2.7% 4.86 EUR 3.57 EUR 0.97 9.61 3.5K On
29 May 2026 5.80 EUR 3.7% 4.82 EUR 3.55 EUR 0.91 5.82 0 On
22 May 2026 5.60 EUR 1.6% 4.79 EUR 3.53 EUR 0.99 5.11 0 On
15 May 2026 5.51 EUR -4.4% 4.76 EUR 3.51 EUR 1.05 5.72 22.6K On
8 May 2026 5.76 EUR 0.3% 4.74 EUR 3.49 EUR 1.04 10.42 0 On
1 May 2026 5.75 EUR -3.0% 4.70 EUR 3.47 EUR 1.06 12.35 1.9K On
24 Apr 2026 5.92 EUR 3.9% 4.67 EUR 3.45 EUR 1.00 17.16 0 On
17 Apr 2026 5.70 EUR 5.4% 4.62 EUR 3.43 EUR 0.90 9.51 1.9K On
10 Apr 2026 5.41 EUR 0.7% 4.59 EUR 3.41 EUR 0.63 6.99 300 Off
3 Apr 2026 5.38 EUR 4.0% 4.56 EUR 3.39 EUR 0.08 13.61 0 Off
27 Mar 2026 5.17 EUR 3.2% 4.52 EUR 3.37 EUR -0.47 13.51 0 Off
20 Mar 2026 5.01 EUR 28.8% 4.49 EUR 3.35 EUR -0.94 11.77 0 Off
13 Mar 2026 3.89 EUR -0.4% 4.46 EUR 3.33 EUR -1.32 -14.02 0 Off